IBDEI12J ; ; 06-AUG-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,18857,1,4,0)
 ;;=4^275.42
 ;;^UTILITY(U,$J,358.3,18857,1,5,0)
 ;;=5^Hypercalcemia
 ;;^UTILITY(U,$J,358.3,18857,2)
 ;;=^59932
 ;;^UTILITY(U,$J,358.3,18858,0)
 ;;=275.41^^105^1223^29
 ;;^UTILITY(U,$J,358.3,18858,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,18858,1,4,0)
 ;;=4^275.41
 ;;^UTILITY(U,$J,358.3,18858,1,5,0)
 ;;=5^Hypocalcemia
 ;;^UTILITY(U,$J,358.3,18858,2)
 ;;=^60542
 ;;^UTILITY(U,$J,358.3,18859,0)
 ;;=276.7^^105^1223^23
 ;;^UTILITY(U,$J,358.3,18859,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,18859,1,4,0)
 ;;=4^276.7
 ;;^UTILITY(U,$J,358.3,18859,1,5,0)
 ;;=5^Hyperkalemia
 ;;^UTILITY(U,$J,358.3,18859,2)
 ;;=^60042
 ;;^UTILITY(U,$J,358.3,18860,0)
 ;;=275.2^^105^1223^19
 ;;^UTILITY(U,$J,358.3,18860,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,18860,1,4,0)
 ;;=4^275.2
 ;;^UTILITY(U,$J,358.3,18860,1,5,0)
 ;;=5^Hyper Or Hypomagnesemia
 ;;^UTILITY(U,$J,358.3,18860,2)
 ;;=^35626
 ;;^UTILITY(U,$J,358.3,18861,0)
 ;;=276.0^^105^1223^25
 ;;^UTILITY(U,$J,358.3,18861,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,18861,1,4,0)
 ;;=4^276.0
 ;;^UTILITY(U,$J,358.3,18861,1,5,0)
 ;;=5^Hypernatremia
 ;;^UTILITY(U,$J,358.3,18861,2)
 ;;=^60144
 ;;^UTILITY(U,$J,358.3,18862,0)
 ;;=276.1^^105^1223^32
 ;;^UTILITY(U,$J,358.3,18862,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,18862,1,4,0)
 ;;=4^276.1
 ;;^UTILITY(U,$J,358.3,18862,1,5,0)
 ;;=5^Hyponatremia
 ;;^UTILITY(U,$J,358.3,18862,2)
 ;;=Hyponatremia^60722
 ;;^UTILITY(U,$J,358.3,18863,0)
 ;;=275.3^^105^1223^20
 ;;^UTILITY(U,$J,358.3,18863,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,18863,1,4,0)
 ;;=4^275.3
 ;;^UTILITY(U,$J,358.3,18863,1,5,0)
 ;;=5^Hyper Or Hypophosphatemia
 ;;^UTILITY(U,$J,358.3,18863,2)
 ;;=^93796
 ;;^UTILITY(U,$J,358.3,18864,0)
 ;;=240.0^^105^1223^14
 ;;^UTILITY(U,$J,358.3,18864,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,18864,1,4,0)
 ;;=4^240.0
 ;;^UTILITY(U,$J,358.3,18864,1,5,0)
 ;;=5^Goiter, Simple
 ;;^UTILITY(U,$J,358.3,18864,2)
 ;;=^259806
 ;;^UTILITY(U,$J,358.3,18865,0)
 ;;=241.1^^105^1223^13
 ;;^UTILITY(U,$J,358.3,18865,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,18865,1,4,0)
 ;;=4^241.1
 ;;^UTILITY(U,$J,358.3,18865,1,5,0)
 ;;=5^Goiter, Nontox, Multinod
 ;;^UTILITY(U,$J,358.3,18865,2)
 ;;=^267790
 ;;^UTILITY(U,$J,358.3,18866,0)
 ;;=241.0^^105^1223^50
 ;;^UTILITY(U,$J,358.3,18866,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,18866,1,4,0)
 ;;=4^241.0
 ;;^UTILITY(U,$J,358.3,18866,1,5,0)
 ;;=5^Thyroid Nodule, Nontoxic
 ;;^UTILITY(U,$J,358.3,18866,2)
 ;;=^83865
 ;;^UTILITY(U,$J,358.3,18867,0)
 ;;=242.00^^105^1223^15
 ;;^UTILITY(U,$J,358.3,18867,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,18867,1,4,0)
 ;;=4^242.00
 ;;^UTILITY(U,$J,358.3,18867,1,5,0)
 ;;=5^Graves' Disease
 ;;^UTILITY(U,$J,358.3,18867,2)
 ;;=^267793
 ;;^UTILITY(U,$J,358.3,18868,0)
 ;;=242.01^^105^1223^12
 ;;^UTILITY(U,$J,358.3,18868,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,18868,1,4,0)
 ;;=4^242.01
 ;;^UTILITY(U,$J,358.3,18868,1,5,0)
 ;;=5^Goiter Diff Tox W Strm
 ;;^UTILITY(U,$J,358.3,18868,2)
 ;;=^267794
 ;;^UTILITY(U,$J,358.3,18869,0)
 ;;=252.1^^105^1223^33
 ;;^UTILITY(U,$J,358.3,18869,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,18869,1,4,0)
 ;;=4^252.1
 ;;^UTILITY(U,$J,358.3,18869,1,5,0)
 ;;=5^Hypoparathyroidism
 ;;^UTILITY(U,$J,358.3,18869,2)
 ;;=^60635
 ;;^UTILITY(U,$J,358.3,18870,0)
 ;;=242.90^^105^1223^27
 ;;^UTILITY(U,$J,358.3,18870,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,18870,1,4,0)
 ;;=4^242.90
 ;;^UTILITY(U,$J,358.3,18870,1,5,0)
 ;;=5^Hyperthyroidism w/o Goiter/Storm
 ;;^UTILITY(U,$J,358.3,18870,2)
 ;;=^267811
 ;;^UTILITY(U,$J,358.3,18871,0)
 ;;=242.91^^105^1223^26
 ;;
 ;;$END ROU IBDEI12J
